rezurockhcp.com - REZUROCK® (belumosudil) | Official HCP Website

Description: REZUROCK is the first and only treatment for cGVHD that selectively inhibits the ROCK2 pathway.

Example domain paragraphs

For US Health Care Professionals Only

An innovative way to treat cGVHD 1-3

REZUROCK is the first and only treatment for cGVHD that selectively inhibits the rock2 pathway. REZUROCK is an immunomodulator that is designed to downregulate inflammation and fibrosis. 1-3

Links to rezurockhcp.com (6)